Odonate Therapeutics, Inc.(NASDAQ : ODT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.14%||170.19||0.7%||$1253.43m|
|MRK||Merck & Co., Inc.||-0.60%||78.22||0.7%||$926.88m|
|BMY||Bristol-Myers Squibb Co.||-0.31%||64.84||1.0%||$719.56m|
|LLY||Eli Lilly & Co.||0.75%||196.40||1.1%||$573.53m|
|BTX||Brooklyn ImmunoTherapeutics, Inc.||-7.43%||21.69||12.8%||$256.18m|
|NVO||Novo Nordisk A/S||0.28%||79.11||0.1%||$72.19m|
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.